{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:44:14Z","timestamp":1768279454773,"version":"3.49.0"},"reference-count":61,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Central serous chorioretinopathy (CSCR) is characterised by retinal serous detachment usually localised in the macular region. CSCR predominantly affects men between 30 and 50\u00a0years of age. Traditional classification differentiates between acute (duration shorter than 4 to 6 months) and chronic disease (duration longer than 4 to 6 months). The pathogenesis is multifactorial and current thinking assumes the presence of localised choroidal hyperpermeability with subsequent secondary changes in the retinal pigment epithelium (RPE). The symptoms of acute CSCR include central blurred vision, often with deterioration in visual acuity. Optical coherence tomography (OCT) reveals subretinal fluid (SRF) and\/or single retinal pigment epithelial detachments. Fluorescein angiography (FA) usually shows a leaking point with absent or only minor RPE changes in the acute phase and indocyanine green angiography (ICG) highlights circumscribed areas of thickened and hyperpermeable choroid.\n\t\t\t\t\tAcute cases may show spontaneous resolution of SRF, but may also recur and\/or become chronic. After the initial diagnosis, spontaneous remission is seen in about 70 to 80% of cases, with a recurrence rate of about 50%. Due to the favourable spontaneous course, it is recommended to wait for 4 to 6 months after the first symptoms manifest. Steroid therapy is considered as a major risk factor. Chronic cases are characterised by slow deterioration in visual acuity with reduced contrast and colour perception. There are extensive RPE changes, with secondary degenerative changes of the photoreceptors. The disease can by complicated by choroidal neovascularisation (CNV), especially in elderly patients. The literature lists a number of treatments: The leakage point (visible in the FA) can be treated by focal laser therapy, either micropulse laser or, if sufficiently distant from the fovea, by argon laser coagulation. Randomised trials in chronic CSCR demonstrated good outcomes\n\t\t\t\t\twith photodynamic therapy. With observation periods ranging from 3 to 6 months, several case series reports found improvement after systemic administration of mineralocorticoid receptor antagonists, carbonic anhydrase inhibitors or non-steroidal anti-inflammatory drugs. In the presence of secondary CNV, anti-VEGF treatment should be initiated. It is unclear whether the combination with PDT might be useful.<\/jats:p>","DOI":"10.1055\/a-1531-5605","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T22:45:50Z","timestamp":1629499550000},"page":"971-979","source":"Crossref","is-referenced-by-count":13,"title":["Central Serous Chorioretinopathy \u2013 an Overview"],"prefix":"10.1055","volume":"238","author":[{"given":"Lieselotte","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"B\u00fchler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Yzer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Radboud Universiteit, Nijmegen, Niederlande"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s003470050310","article-title":"[Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects]","volume":"95","author":"H C G\u00e4ckle","year":"1998","journal-title":"Ophthalmologe"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00006982-200506000-00005","article-title":"Fluorescein angiographic features of asymptomatic eyes in central serous chorioretinopathy","volume":"25","author":"D Bujarborua","year":"2005","journal-title":"Retina"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0002-9394(14)75205-5","article-title":"Central serous retinopathy in a 7-year-old girl","volume":"90","author":"S L Fine","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"R F Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physio-pathology hypothesis","volume":"48","author":"A Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":"The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002","volume":"115","author":"A S Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"key":"ref7","first-page":"10","article-title":"Stellungnahme des Berufsverbandes der Augen\u00e4rzte Deutschlands, der Deutschen Ophthalmologischen Gesellschaft und der Retinologischen Gesellschaft zur Chorioretinopathia centralis serosa (CCS)","volume":"116","author":"C Lange","year":"2019","journal-title":"Ophthalmologe"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk Factors for Central Serous Chorioretinopathy: A Systematic Review and Meta-Analysis","volume":"36","author":"B Liu","year":"2016","journal-title":"Retina"},{"key":"ref9","first-page":"587\/515","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63","author":"J D Gass","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00225936","article-title":"Indocyanine green angiography of central serous chorioretinopathy","volume":"9","author":"K Hayashi","year":"1986","journal-title":"Int Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":"Indocyanine green videoangiography of older patients with central serous chorioretinopathy","volume":"16","author":"R F Spaide","year":"1996","journal-title":"Retina"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Y Imamura","year":"2009","journal-title":"Retina"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment","volume":"58","author":"B Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: Towards an evidence-based treatment guideline","volume":"73","author":"T J van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","article-title":"Acute Central Serous Chorioretinopathy: Factors Influencing Episode Duration","volume":"37","author":"A Daruich","year":"2017","journal-title":"Retina"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.eye.6700637","article-title":"Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy","volume":"18","author":"R Wong","year":"2004","journal-title":"Eye (Lond)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/IAE.0000000000001729","article-title":"Risk factors for recurrences of central serous chorioretinopathy","volume":"38","author":"A Matet","year":"2017","journal-title":"Retina"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1600-0420.2005.00582.x","article-title":"Clinical characteristics of subretinal deposits in central serous chorioretinopathy","volume":"83","author":"M Wang","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e776","DOI":"10.1111\/aos.13665","article-title":"Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient\u02bcs subjective handicap in acute central serous chorioretinopathy","volume":"96","author":"B S Gerendas","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"ref20","first-page":"350","article-title":"Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy","volume":"7","author":"M Y Teke","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0161-6420(84)34117-3","article-title":"Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy","volume":"91","author":"L Yannuzzi","year":"1984","journal-title":"Ophthalmology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200302000-00001","article-title":"Cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"23","author":"T Iida","year":"1984","journal-title":"Retina"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/IAE.0000000000001580","article-title":"Optical Coherence Tomography Angiography of Flat Irregular Pigment Epithelium Detachment in Chronic Central Serous Chorioretinopathy","volume":"38","author":"E Bousquet","year":"2018","journal-title":"Retina"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2147\/OPTH.S242926","article-title":"Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy","volume":"14","author":"D Mohabati","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/OPTH.S174573","article-title":"Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy","volume":"12","author":"D Mohabati","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"C MG Cheung","year":"2019","journal-title":"Eye (Lond)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/IAE.0000000000003057","article-title":"The Ambiguity of Pachychoroid","volume":"41","author":"R F Spaide","year":"2021","journal-title":"Retina"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2007.08.024","article-title":"Elongation of photoreceptor outer segment in central serous chorioretinopathy","volume":"145","author":"H Matsumoto","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/IAE.0000000000000001","article-title":"Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy","volume":"34","author":"O Yalcinbayir","year":"2014","journal-title":"Retina"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/IAE.0b013e31816b4b86","article-title":"Posterior cystoid retinal degeneration in central serous chorioretinopathy","volume":"28","author":"F C Piccolino","year":"2008","journal-title":"Retina"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40123-018-0159-1","article-title":"OCT Angiography of the Choriocapillaris in Central Serous Chorioretinopathy: A Quantitative Subgroup Analysis","volume":"8","author":"B Cakir","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s10792-020-01376-7","article-title":"Swept-source optical coherence tomography angiography alleviates shadowing artifacts caused by subretinal fluid","volume":"40","author":"M Reich","year":"2020","journal-title":"Int Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3928\/23258160-20150909-07","article-title":"A central hyporeflective subretinal lucency correlates with a region of focal leakage on fluorescein angiography in eyes with central serous chorioretinopathy","volume":"46","author":"N A Yannuzzi","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref34","first-page":"718","article-title":"In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics","volume":"36","author":"F C Delori","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00417-014-2899-5","article-title":"Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT","volume":"253","author":"P Iacono","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ophtha.2005.01.003","article-title":"Fundus autofluorescence and central serous chorioretinopathy","volume":"112","author":"R F Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e0202549","DOI":"10.1371\/journal.pone.0202549","article-title":"Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"13","author":"T J van Rijssen","year":"2018","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/eye.1987.18","article-title":"Retinal dysfunction in central serous retinopathy","volume":"1","author":"E L Chuang","year":"1987","journal-title":"Eye (Lond)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10792-016-0377-2","article-title":"Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy","volume":"37","author":"F Pichi","year":"2016","journal-title":"Int Ophthalmol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/IAE.0000000000001649","article-title":"A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy","volume":"38","author":"E Rahimy","year":"2018","journal-title":"Retina"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1111\/aos.13491","article-title":"Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study","volume":"95","author":"R Schwartz","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(19)32981-2","article-title":"Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"A Lotery","year":"2020","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2147\/OPTH.S12583","article-title":"Low-dose aspirin as treatment for central serous chorioretinopathy","volume":"4","author":"A Caccavale","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0161-6420(02)01157-0","article-title":"Acetazolamide for central serous retinopathy","volume":"109","author":"J Pikkel","year":"2002","journal-title":"Ophthalmology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.72.11.829","article-title":"Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy","volume":"72","author":"L Ficker","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":"Subfoveal choroidal thickness after treatment of central serous chorioretinopathy","volume":"117","author":"I Maruko","year":"2010","journal-title":"Ophthalmology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"C M Gilbert","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s12325-017-0559-y","article-title":"A review of subthreshold micropulse laser for treatment of macular disorders","volume":"34","author":"P Scholz","year":"2017","journal-title":"Adv Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"W M Chan","year":"2008","journal-title":"Ophthalmology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IAE.0000000000001138","article-title":"Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy","volume":"37","author":"C K Cheng","year":"2017","journal-title":"Retina"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bjophthalmol-2014-305353","article-title":"Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy","volume":"99","author":"C C Tseng","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajo.2011.08.015","article-title":"Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy","volume":"153","author":"M Nicol\u00f2","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the place trial","volume":"125","author":"E HC van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/IAE.0b013e31820a6a17","article-title":"Concentration of cytokines in the aqueous humor of patients with central serous chorioretinopathy","volume":"31","author":"M C Shin","year":"2011","journal-title":"Retina"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajo.2011.04.008","article-title":"A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy","volume":"152","author":"S H Bae","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/eye.2013.236","article-title":"Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review","volume":"27","author":"Y R Chung","year":"2013","journal-title":"Eye (Lond)"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and Safety of Ranibizumab for the Treatment of Choroidal Neovascularization due to Uncommon Cause: Twelve-Month Results of the MINERVA Study","volume":"38","author":"T YY Lai","year":"2018","journal-title":"Retina"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/IAE.0b013e31826710a0","article-title":"Early changes in foveal thickness in eyes with central serous chorioretinopathy","volume":"33","author":"M Hata","year":"2013","journal-title":"Retina"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.63.10.674","article-title":"Argon laser photocoagulation in the treatment of central serous retinopathy","volume":"63","author":"P Leaver","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"S Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"ref61","first-page":"T8","article-title":"Long-term outcome of half-dose verteporfin photodynamic therapy for the treatment of central serous chorioretinopathy (an american ophthalmological society thesis)","volume":"113","author":"T Y Lai","year":"2015","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1531-5605.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T22:42:42Z","timestamp":1631054562000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1531-5605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":61,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2021,9,7]]},"published-print":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1531-5605","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]}}}